MAE-WEST RSC - Eicosanoids Profiling Core
MAE-WEST RSC - 类二十烷酸分析核心
基本信息
- 批准号:10198759
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcidsAgeAgingAlzheimer&aposs disease related dementiaAnimal ModelAnimalsAnti-Inflammatory AgentsArachidonic AcidsBasic ScienceBioinformaticsBiologicalBiological AgingBiological AssayBiological ProcessBiometryBlood CirculationBlood VesselsBrainCardiologyCenters of Research ExcellenceChronicChronic Kidney FailureChronologyClinical ResearchComplexCore FacilityDataDevelopmentDiseaseEFRACEicosanoidsEicosapentaenoic AcidElderlyEndothelial CellsEndotheliumEnsureEpidemiologistEquilibriumEvaluationExhibitsFailureFamilyFemaleFoundationsFunctional disorderFundingGenerationsGeriatricsGoalsGonadal Steroid HormonesGrantHeart failureHumanIndividualInflammationInflammatoryInflammatory ResponseInfrastructureLife Cycle StagesLipidsLongevityMass Spectrum AnalysisMeasuresMediator of activation proteinMetabolic syndromeMethodologyMethodsMicrovascular DysfunctionMolecularMorbidity - disease rateNatureNephrologyObesityOrganOrganization and AdministrationPhysiologicalPilot ProjectsPlasmaPlayPolyunsaturated Fatty AcidsPopulation StudyPublic HealthRenal functionReproducibilityRequest for ApplicationsResearch MethodologyResearch PersonnelResolutionResource SharingResourcesRiskRoleSamplingScientific Advances and AccomplishmentsScientistServicesSex DifferencesSpecialized CenterStandardizationStressStructureSystemTNF geneTimeTrainingVariantWomanWorkadvanced analyticsage effectage relatedburden of illnesscareerclinical developmentcohortcomputational chemistrycytokinedata handlingdata standardseffective interventionexperiencefrailtygamma-Linolenic Acidheart functionhigh dimensionalityimprovedin vivoindexinginflammatory markerinsightliquid chromatography mass spectrometrymalemenmicrovascular agingnovelpreservationprospectiveresponsesexsex disparitysexual dimorphismstressorsystemic inflammatory responsetooltranslational scientist
项目摘要
Project Abstract – MAE-WEST SCORE Eicosanoids Profiling Core
Over the course of life, chronic stressors contribute to multi-organ aging and dysfunction and, ultimately, the
development of clinical disease. Sex remains a critical determinant of the nature and pace of aging and ultimately
longevity. Among mammalian species, it is even more clear that females fundamentally age differently from
males. With advancing chronologic age in humans, differences in biological aging between women and men
become even more pronounced, culminating in the female predominance for a number of important morbid
disease conditions, including notably Alzheimer’s disease and related dementias (ADRD), heart failure with
preserved ejection fraction (HFpEF), progressive chronic kidney disease (CKD), and in turn systemic frailty.
Mechanisms underlying the female predominance for these major morbidities remains unknown and are not
explained by variations in sex hormones or survival bias. Our preliminary work supports a central hypothesis that
sexual dimorphism in inflammatory eicosanoid mediators contribute to sex differences in microvascular
dysfunction and, in turn, to sex differences in age-related multi-organ disease, including for ADRD, HFpEF and
CKD. Elucidating a common pathophysiologic basis for the female predominance of ADRD, HFpEF, and CKD
holds the key to effective interventions for reducing the excess burden of age-related disease in women. We
propose to establish the Microvascular Aging and Eicosanoids – Women’s Evaluation of Systemic aging Tenacity
(MAE-WEST) (“You are never too old to become younger!”) Specialized Center of Research Excellence
(SCORE) on Sex Differences, in response to NIH RFA-OD-19-013. Our goal is to form a robust and sustainable
structure of academic activities centered on systematically interrogating sex differences in the relationship
among eicosanoids, microvascular dysfunction, and age-related end-organ disease, with an initial focus on the
microvascular aging effects on brain, heart, and kidney function. This goal will be achieved by an outstanding
collaborative team of clinician-scientists (with expertise in geriatrics, cardiology, and nephrology),
epidemiologists, basic and translational scientists, analytical chemists, biostatisticians, and bioinformaticians.
Leveraging our collective experience, resources, and infrastructure, we will advance the scientific enterprise
through 3 foundational projects aligned and complementary yet independent. We will establish a dedicated
Resource Support Core - an Eicosanoids Profiling Core (EPC) that will be intentionally created as standalone
organization within the larger MAE-WEST SCORE. This organizational feature will not only maximize resource
sharing across the project aims but also ensure the ability to separately and independently augment the
methodological training of early career investigators and, importantly, timely provision of in-kind services for
trainee pilot projects. The dedicated effort of the EPC will allow efficient generation of preliminary data for
acquiring additional and ancillary grant funding for both early career and core activities, which will additionally
contribute to the long-term sustainability of the MAE-WEST SCORE as a whole.
项目摘要 – MAE-WEST SCORE 类二十烷酸分析核心
在生命过程中,慢性压力源会导致多器官衰老和功能障碍,并最终导致
临床疾病的发展仍然是衰老的性质和速度的关键决定因素。
在哺乳动物物种中,更明显的是,雌性的寿命与雌性的寿命根本不同。
随着人类年龄的增长,女性和男性之间的生物衰老存在差异。
变得更加明显,最终导致一些重要病态的女性占主导地位
疾病状况,特别是阿尔茨海默氏病和相关痴呆症 (ADRD)、心力衰竭
射血分数保留(HFpEF)、进行性慢性肾病(CKD)以及全身虚弱。
这些主要疾病的女性占主导地位的机制仍然未知,也不清楚
我们的初步工作支持一个中心假设:
炎症类二十烷酸介质的性别二态性导致微血管的性别差异
功能障碍,进而导致与年龄相关的多器官疾病的性别差异,包括 ADRD、HFpEF 和
阐明 ADRD、HFpEF 和 CKD 女性占主导地位的共同病理生理学基础
是采取有效干预措施减少妇女因年龄相关疾病而过度负担的关键。
提议建立微血管衰老与类二十烷酸——女性全身衰老韧性评估
(MAE-WEST)(“你永远不会太老而变得年轻!”)卓越研究专业中心
(SCORE) 性别差异,响应 NIH RFA-OD-19-013 我们的目标是形成一个强大且可持续的体系。
以系统地探讨关系中的性别差异为中心的学术活动结构
类二十烷酸、微血管功能障碍和与年龄相关的终末器官疾病,最初的重点是
微血管老化对大脑、心脏和肾脏功能的影响将通过出色的表现来实现。
临床医生-科学家协作团队(具有老年病学、心脏病学和肾病学专业知识),
流行病学家、基础科学家和转化科学家、分析化学家、生物统计学家和生物信息学家。
利用我们的集体经验、资源和基础设施,我们将推进科学事业
通过三个基础项目的协调和互补,我们将建立一个专门的项目。
资源支持核心 - 类二十烷酸分析核心 (EPC),将特意创建为独立的
在更大的 MAE-WEST SCORE 中进行组织 这种组织功能不仅可以最大限度地利用资源。
跨项目目标共享,但也确保能够单独和独立地增强
对早期职业调查员进行方法培训,重要的是,及时向他们提供实物服务
EPC 的专门努力将有助于有效生成初步数据。
为早期职业生涯和核心活动获取额外和辅助赠款资金,这将另外
为整个 MAE-WEST SCORE 的长期可持续性做出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohit Jain其他文献
Mohit Jain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohit Jain', 18)}}的其他基金
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
生物活性代谢物调节癌症免疫治疗中与免疫相关的不良事件
- 批准号:
10447679 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
生物活性代谢物调节癌症免疫治疗中与免疫相关的不良事件
- 批准号:
10318063 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
MAE-WEST RSC - Eicosanoids Profiling Core
MAE-WEST RSC - 类二十烷酸分析核心
- 批准号:
10450759 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease
绘制血浆暴露体图谱及其与人类心血管疾病的关系
- 批准号:
9233700 - 财政年份:2017
- 资助金额:
$ 24.9万 - 项目类别:
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy
绘制人类心肌病干细胞衍生模型的代谢活动图谱
- 批准号:
9170227 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy
绘制人类心肌病干细胞衍生模型的代谢活动图谱
- 批准号:
9329477 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:
Reactive electrophiles in human aging and longevity
反应性亲电子试剂在人类衰老和长寿中的作用
- 批准号:
9323237 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:
Reactive electrophiles in human aging and longevity
反应性亲电子试剂在人类衰老和长寿中的作用
- 批准号:
9162248 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:
A systems approach to metabolic dysregulation in the heart
心脏代谢失调的系统方法
- 批准号:
8448190 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
A2E老化ARMS2/HTRA1型iPSC-RPE细胞的研究:个体化AMD发病机制初步探索
- 批准号:81400412
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mineral Coated Microparticles for Stabilization and Delivery of Complexed mRNA for Healing of Long Bone Defects
用于稳定和递送复合 mRNA 的矿物涂层微粒,用于治疗长骨缺损
- 批准号:
10464358 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Multi-Omics Predictors of Oral HPV Outcomes among PLWH
PLWH 口腔 HPV 结果的多组学预测
- 批准号:
10557585 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Hepatic Lipotoxicity, Metabolic Homeostasis and NAFLD Pathogenesis
肝脏脂毒性、代谢稳态和 NAFLD 发病机制
- 批准号:
10886869 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:
10679988 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: